KI makes final submission to the Swedish Research Council’s national evaluation of medical research
On 5 November, KI submitted its final batch of material to the Swedish Research Council’s national evaluation of preclinical medical and pharmaceutical science for 2024-25. Seven universities are participating in the process, which aims to provide a national picture of the research field.
The Swedish Research Council conducts subject-based evaluations on behalf of the government in order to provide a national picture of the scientific quality and value of the research being done in the related subjects, to promote the development of Swedish research and to provide a basis for quality development.
The Swedish Research Council has devised a two-part evaluation model: publications inform the quality assessment of scientific production, while case studies inform the assessment of the societal impact of the research.
It has been a major challenge for KI to sift out the best publications and case studies, explains Vice-President Martin Bergö, who has chaired the internal assessment team.
“We’re happy to have submitted these publications and case studies, the former demonstrating KI’s excellent world-class research and the latter from its researchers at different stages of their career around KI, demonstrating the depth and breadth of our research,” he says. “The material we’re submitting also shows how KI’s collaborative research is used for the benefit of society, both in Sweden and around the world.”
The number of publications and case studies that the Swedish Research Council has requested is in proportion to the size of the university’s scientific production and research and teaching staff. KI has submitted some 150 top publications and 15 case studies, more than any of the other participating institutions.
Clear selection criteria
The Swedish Research Council issues clear requirements for the material to be submitted. For example, the KI researchers must be the first, last or corresponding author.
While the Swedish Research Council performs a bibliometric analysis of the total volume of scientific publications, each university has been asked to select a number of top publications from 2018 or earlier.
The case studies are intended to describe research impacts between 2018 and 2024, for which the underlying research is to have been published in the past twenty years. Suggestions for case studies have been made by researchers.
“It’s impressive to see all the brilliant research produced at KI,” says Professor Bergö. “We’re also grateful to the researchers for all their help describing the case studies, for which we’re currently planning to demonstrate how the research outcomes generated at KI over the past two decades have benefited society.”
All ten research fields (see below) are represented in the submitted publications, although neurosciences, immunology, cell biology, biochemistry and molecular biology dominate – a reflection of the number of active researchers at KI.
The submitted case studies include the development of new guidelines, therapies, methods and vaccines.
Selection process at KI
KI set up an internal assessment team last spring comprising experts in the relevant research fields and chaired by Vice-President Martin Bergö. Additional experts have been consulted when necessary.
Staff from the Research and Doctoral Education Unit (FFU), Research Support Office (RSO) and KI University Library have provided administrative and other support.
The Swedish Research Council is now evaluating the submitted material with the help of a panel mainly composed of international experts and is expected to present its report by next April, after which meetings will be held between panel representatives and the participating universities.
Seven institutions and ten research subjects
The participating universities are Karolinska Institutet and the universities of Uppsala, Lund, Gothenburg, Linköping, Umeå and Örebro.
Each institution has decided for itself how the selection of publications and case studies was made. The evaluation concerns research outcomes for the years 2018-2024.
The Swedish Research Council’s evaluation of the research field of preclinical medical and pharmaceutical sciences from 2018 to 2024 comprises ten different subjects:
- Biochemistry and molecular biology
- Cell biology
- Medicinal chemistry
- Medicinal genetics
- Immunology
- Microbiology
- Neurosciences
- Pharmacology
- Physiology
- Toxicology